UCB Completes Acquisition of Zogenix, Inc. : vimarsana.com

BRUSSELS, Belgium and ATLANTA, March 7, 2022 /PRNewswire/ -- UCB today announced the successful completion of the previously announced transaction to acquire Zogenix for US$ 26.00 per... | March 7, 2022

Related Keywords

Japan , United States , Brussels , Bruxelles Capitale , Belgium , Smyrna , Izmir , Turkey , Charl Van Zyl , Erica Puntel , Nick Francis , Antje Witte , Laurent Schots , Neurology Head Of Europe International , Twitter , Ucb Inc , Drug Administration , Zogenix Inc , Program See Boxed Warning , Nasdaq , Zogenix Press , Corporate Communications , European Medicines Agency , Source Ucb Inc , Euronext , Executive Vice President , International Markets , Prescribing Information , Boxed Warning , Heart Disease , Pulmonary Arterial Hypertension , Mitigation Strategy , Decreased Weight , Antiepileptic Drugs , Blood Pressure , Euronext Brussels , Variation Application , Seizures Associated , Priority Review , Supplemental New Drug Application , Lennox Gastaut Syndrome , Zogenix , Nc Stock Exchange , News , Information , Press Release , End , Arch , 022 , Cb , Oday , Nnounced , The , Uccessful , Completion , F , Reviously , Transaction , O , Cquire , Rogenix , Or Zgnx Us98978l2043 ,